BioAtla, Inc. (BCAB)
0.1711
+0.01
(+4.14%)
USD |
NASDAQ |
Feb 20, 10:34
BioAtla EPS Diluted (Quarterly) : -0.2686 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2126 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Annovis Bio, Inc. | -0.3689 |
| Azitra, Inc. | -0.6714 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.78M |
| Total Expenses (Quarterly) | 15.78M |
| Enterprise Value | 8.383M |
| Earnings Yield | -671.9% |
| Normalized Earnings Yield | -674.87 |